PREMIUM
Business
Mauritius investment firm buys Cipla Uganda
Currently, Meditab Holdings owns 51.05% or 1,864,299,646 shares in CQCIL and Cipla EU Limited holds 0.13% or 4,871,038 shares
CQCIL reported a 393% surge in profits after tax for the six months’ period ended September 2022. (Courtesy photo)
By: NewVision Reporter, Journalists @NewVision
A Mauritius-based investment firm is buying a controlling stake in Cipla Quality Chemicals Industries Limited (CQCIL), the largest pharmaceutical in East Africa based in Uganda.
CQCIL said